Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.
Explore this paper's citation graph
Summary
A target-driven, long-term, intensified intervention aimed at multiple risk factors in patients with type 2 diabetes and microalbuminuria reduces the risk of cardiovascular and microvascular events by about 50 percent.
- Type
- article
- Published
- 2003-01-30
- Cited by
- 4,522
- References
- 22
- Access
- Open access
- OpenAlex
- https://openalex.org/W2139634859
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:39218251
Keywords
Medicine, Hazard ratio, Internal medicine, Microalbuminuria, Type 2 diabetes
References
- Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
- Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.
- Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.
- Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM Complications Study
- Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial
- A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women.
- Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)
- Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European Type 2 (non-insulin-dependent) diabetic patients
- Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study.
- Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23)
- Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.
- Albuminuria and Poor Glycemic Control Predict Mortality in NIDDM
- Diabetes and cardiovascular disease. The Framingham study.
- Diabetes and decline in heart disease mortality in US adults.
- Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension *
- Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.
- The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.
- Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes.
Cited by
- Quality of Diabetes Care: A cross-sectional observational study in Oman.
- Effects of protocol-driven care versus usual outpatient clinic care on survival rates in patients with type 2 diabetes.
- Iperomocisteinemia e rischio cardiovascolare nel diabete: fantasia o realtà?
- Identifying risk of type 2 diabetes : epidemiologic perspectives from biomarkers to lifestyle
- Diabetes prevention: perspectives and actions of one company.
- Cardiac rehabilitation in community settings.
- Progression of renal insufficiency in type 2 diabetes with and without microalbuminuria: results of the Heart Outcomes and Prevention Evaluation (HOPE) randomized study.
- The Utility of Insulin Glargine in the Treatment of Diabetes Mellitus
- Early vascular risk factor modification in type 1 diabetes.
- Atherosclerotic Cardiovascular Disease Risk in the HAART-Treated HIV-1 Population
- Caring for Patients with Chronic Kidney Disease: A Joint Opinion of the Ambulatory Care and the Nephrology Practice and Research Networks of the American College of Clinical Pharmacy
- Chirurgie im Alter aus Sicht der Krankenkassen
- Health perceptions of diabetic patients in the REDIA study.
- Assessment of diabetes screening by general practitioners in France: the EPIDIA Study
- The Role of Glycosaminoglycans and Sulodexide in the Treatment of Diabetic Nephropathy
- Diabetes guidelines: easier to preach than to practise?
- Diabetes Nutrition and Complications Trial: adherence to the ADA nutritional recommendations, targets of metabolic control, and onset of diabetes complications. A 7-year, prospective, population-based, observational multicenter study.
- Implications of hyperglycaemia and ethnicity in patients with acute coronary syndromes in New Zealand
- ‘Beyond blood pressure’ means multiple risk factor intervention, not pleiotropic antihypertensive drugs
- Fixed-dose combinations improve medication compliance: a meta-analysis.
Related papers
- Microalbuminuria, is it so important?
- A study of predictive value of microalbuminuria in early outcome of non-diabetic patients of acute myocardial infarction
- Relationship between C reactive protein and urinary albumin excretion rate in type 2 diabetes
- Rate of Progression of Albuminuria in Type II Diabetes: Five-year prospective study from South India
- Macroalbuminuria and microalbuminuria: do both predict renal and cardiovascular events with similar strength?
- Microalbuminuria: do we need a new threshold?
- Detection and clinical significance of sICAM-1 in type 2 diabetic patients with microalbuminuria
- Change in Albuminuria Is Predictive of Cardiovascular Outcome in Normotensive Patients With Type 2 Diabetes and Microalbuminuria
- Screening, monitoring, and treatment of albuminuria: Public health perspectives.
- Frequency of Hypercholesterolemia in Recent Onset Type – 2 Diabetics with Microalbuminuria